Zenas BioPharma, Inc. (ZBIO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 730.16M | 351.17M | 296.64M | 278.6M | 317.81M | 355.92M | 393.78M | 188.6M | 39.7M | 59.8M | 76.68M |
| Cash & Short-Term Investments | 717.21M | 343.19M | 290.88M | 273.28M | 312.38M | 350.77M | 386.8M | 183.93M | 37.15M | 56.86M | 72.31M |
| Cash Only | 500.22M | 110.64M | 115.56M | 44.01M | 196.55M | 319.74M | 360.04M | 183.93M | 37.15M | 56.86M | 72.31M |
| Short-Term Investments | 216.98M | 232.55M | 175.32M | 229.27M | 115.83M | 31.02M | 26.76M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 11.86M | 7.98M | 5.76M | 1.3M | 5.43M | 5.16M | 6.98M | 1.2M | 2.55M | 2.95M | 0 |
| Total Non-Current Assets | 17.52M | 32.47M | 25.38M | 14.48M | 15.96M | 14.04M | 9.65M | 11.35M | 9.35M | 8.38M | 7.12M |
| Property, Plant & Equipment | 1.12M | 1.39M | 857K | 1.07M | 1.28M | 1.19M | 545K | 706K | 847K | 1.01M | 1.15M |
| Fixed Asset Turnover | - | - | - | - | 8.11x | 5.77x | - | - | - | - | 43.59x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.34M | 17.27M | 10.72M | 1.61M | 1.83M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 15.06M | 13.81M | 13.8M | 11.8M | 12.85M | 12.86M | 9.11M | 10.65M | 8.5M | 7.36M | 5.97M |
| Total Assets | 747.68M | 383.64M | 322.02M | 293.08M | 333.77M | 369.97M | 403.43M | 199.95M | 49.05M | 68.18M | 83.79M |
| Asset Turnover | - | - | - | - | 0.03x | 0.01x | - | - | - | - | 0.60x |
| Asset Growth % | 124.01% | 3.7% | -20.18% | 46.58% | 580.45% | 442.63% | 381.47% | - | - | - | - |
| Total Current Liabilities | 61.16M | 62.65M | 52.42M | 53.24M | 49.13M | 57.29M | 44M | 39.11M | 30.33M | 23.26M | 15.56M |
| Accounts Payable | 8.94M | 7.11M | 6.44M | 7.93M | 20.02M | 17.14M | 15.08M | 8.36M | 8.83M | 5.4M | 2.28M |
| Days Payables Outstanding | 120.41K | - | 132.25 | 29.56 | - | - | 32.16 | 23.13 | 28.58 | 17.28 | - |
| Short-Term Debt | 1.04M | 1.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 45.44M | 54.3M | 8.76M | 0 | 3.38M | 8.31M | 6.19M | 530K | 3.72M | 5.12M | 4.12M |
| Current Ratio | 11.94x | 5.61x | 5.66x | 5.23x | 6.47x | 6.21x | 8.95x | 4.82x | 1.31x | 2.57x | 4.93x |
| Quick Ratio | 11.94x | 5.61x | 5.66x | 5.23x | 6.47x | 6.21x | 8.95x | 4.82x | 1.31x | 2.57x | 4.93x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 350.69M | 78.85M | 73.17M | 215K | 317K | 218K | 0 | 14K | 271.21M | 270.64M | 270.47M |
| Long-Term Debt | 350.62M | 78.64M | 0 | 0 | 0 | 0 | 0 | 0 | 20.99M | 20.3M | 20M |
| Capital Lease Obligations | 77K | 211K | 180K | 215K | 317K | 218K | 0 | 14K | 133K | 257K | 381K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 72.99M | 0 | 0 | 0 | 0 | 0 | 250.09M | 250.09M | 250.09M |
| Total Liabilities | 411.85M | 141.5M | 125.59M | 53.46M | 49.45M | 57.51M | 44M | 39.12M | 301.55M | 293.9M | 286.02M |
| Total Debt | 351.73M | 79.96M | 798K | 1.01M | 1.23M | 1M | 384K | 508K | 21.64M | 21.11M | 20.96M |
| Net Debt | -148.5M | -30.68M | -114.77M | -43M | -195.33M | -318.74M | -359.65M | -183.42M | -15.51M | -35.74M | -51.35M |
| Debt / Equity | 1.05x | 0.33x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | 0.59x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | -1.44x |
| Interest Coverage | -11.66x | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 335.83M | 242.14M | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M | 160.83M | -252.5M | -225.72M | -202.23M |
| Equity Growth % | 18.12% | -22.5% | -45.35% | 48.99% | 212.6% | 238.43% | 277.73% | - | - | - | - |
| Book Value per Share | 6.04 | 5.21 | 4.66 | 5.72 | 6.80 | 7.48 | 8.60 | 4.20 | -6.59 | -5.89 | -4.84 |
| Total Shareholders' Equity | 335.83M | 242.14M | 196.43M | 239.63M | 284.32M | 312.46M | 359.44M | 160.83M | -252.5M | -225.72M | -202.23M |
| Common Stock | 6K | 5K | 4K | 4K | 4K | 4K | 4K | 1K | 1K | 0 | 1K |
| Retained Earnings | -846.12M | -765.13M | -524.69M | -473.19M | -420.96M | -387.39M | -334.79M | -296.18M | -258.2M | -230.4M | -205.82M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -377K | -64K | -69K | -94K | 141K | 194K | 54K | 104K | 74K | 37K | 124K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |